VLB 01
Alternative Names: AED; Beprodon; beprodone; Remegal; VLB-01Latest Information Update: 02 Oct 2021
At a glance
- Originator MarcoPolo Pharmaceuticals SA
- Class Antiepileptic drugs
- Mechanism of Action Melatonin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Partial epilepsies
Most Recent Events
- 12 Feb 2016 No development reported - Phase-III for Partial epilepsies (Adjuvant therapy) in Russia (unspecified route)
- 01 Mar 2012 Phase-III clinical trials in Partial seizures (adjunctive therapy) in Russia (unspecified route)